eli lilly tirzepatide news today launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). The device gives patients an additional, potentially more convenient option for taking the drug: They can FDA Approves Lilly's Zepbound™ (tirzepatide)

Uma novidade da retatrutida que ela age nos receptores de trs hormnios diferentes

Generally, glutathiones role in cellular function positions it as a possible therapeutic agent for protecting periodontal health by its antioxidant properties and its capacity to maintain oxidative-reductive balance

A study by Xiao et al

By inhibiting cysteine importation, we were able to interrupt melatonin-induced GSH accumulation and found that in doing so we also suppressed the anti-inflammatory effects of melatonin treatment

Lancet Diabetes Endocrinol 2:5664

The EMA's Pharmacovigilance Risk Assessment Committee (PRAC) has reviewed this signal for the GLP-1 drug class